The risk factors of endometrial cancer
Gerber, J.; Sozański, L.; Suchocki, S.
Ginekologia Polska 72(12a): 1418-1422
2001
ISSN/ISBN: 0017-0011 PMID: 11883289 Document Number: 537620
Authors presents the risk factors in endometrial cancer underlying such problems like hyperestrogenism, both external and internal caused by hormonally active ovarian masses, polycystic ovarian syndrome, adrenocortical hyperfunction and role of obesity in this pathological state. Other factors have been also described diabetes mellitus and hypertension, oral contraception, genetics factors, patient's obstetric history and other diseases where the increase of aromatization activity of androstendion to estron has been noted.
Document emailed within 1 workday
Related Documents
Hale, G.E.; Hughes, C.L.; Cline, J.M. 2002: Endometrial cancer: hormonal factors, the perimenopausal "window of risk," and isoflavones Journal of Clinical Endocrinology and Metabolism 87(1): 3-15Schonfeld, S.J.; Hartge, P.; Pfeiffer, R.M.; Freedman, D.M.; Greenlee, R.T.; Linet, M.S.; Park, Y.; Schairer, C.; Visvanathan, K.; Lacey, J.V. 2013: An aggregated analysis of hormonal factors and endometrial cancer risk by parity Cancer 119(7): 1393-1401
Felix, A.S.; Gaudet, M.M.; La Vecchia, C.; Nagle, C.M.; Shu, X.O.; Weiderpass, E.; Adami, H.O.; Beresford, S.; Bernstein, L.; Chen, C.; Cook, L.S.; De Vivo, I.; Doherty, J.A.; Friedenreich, C.M.; Gapstur, S.M.; Hill, D.; Horn-Ross, P.L.; Lacey, J.V.; Levi, F.; Liang, X.; Lu, L.; Magliocco, A.; McCann, S.E.; Negri, E.; Olson, S.H.; Palmer, J.R.; Patel, A.V.; Petruzella, S.; Prescott, J.; Risch, H.A.; Rosenberg, L.; Sherman, M.E.; Spurdle, A.B.; Webb, P.M.; Wise, L.A.; Xiang, Y.-B.; Xu, W.; Yang, H.P.; Yu, H.; Zeleniuch-Jacquotte, A.; Brinton, L.A. 2015: Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium International Journal of Cancer 136(5): E410-E422
Muallem, M.Zelal.; Sehouli, J.; Almuheimid, J.; Richter, R.; Joukhadar, R.; Plett, H. 2016: Risk Factors of Lymph Nodes Metastases by Endometrial Cancer: A Retrospective One-center Study Anticancer Research 36(8): 4219-4225
Mangili, G.; De Marzi, P.; Viganò, R.; Rabaiotti, E.; Sassi, I.; Taccagni, G.L.; Garancini, P.; Frigerio, L. 2002: Identification of high risk patients with endometrial carcinoma. Prognostic assessment of endometrial cancer European Journal of Gynaecological Oncology 23(3): 216-220
Chovanec, J.; Bienertová-Vasků, J.A.; Dostálová, Z.; Janků, M. 2007: Cholecystectomy--the risk factors for endometrial carcinoma? Ceska Gynekologie 72(6): 419-423
Salmi, T. 1980: Endometrial carcinoma risk factors, with special reference to the use of oestrogens Acta Endocrinologica. Supplementum 233: 37-43
Benshushan, A.; Paltiel, O.; Rojansky, N.; Brzezinski, A.; Laufer, N. 2002: IUD use and the risk of endometrial cancer European Journal of Obstetrics Gynecology and Reproductive Biology 105(2): 166-169
Labastida, R.; Dexeus, S.; Fábregas, R.; Tresserra, F.; Fernández, A. 2003: Endometrial cancer: factors affecting survival European Journal of Gynaecological Oncology 24(5): 381-383
Persson, I. 1984: Estrogen treatment and the risk of endometrial cancer Lakartidningen 81(20): 2068-2071
Sommer, H.; Nöschel, H.; Kloetzer, K.H.; Kob, D.; Stech, D. 1989: Results of therapy of endometrial carcinoma and analysis of risk factors in comparison with a control group Archiv für Geschwulstforschung 59(3): 191-197
Kasai, T.; Takeda, B.; Takamizawa, H. 1984: Studies on the early diagnosis of endometrial carcinoma. Analysis of risk factors and cytological approach Nihon Sanka Fujinka Gakkai Zasshi 36(6): 865-874
Neri, F.; Maggino, T. 2009: Surveillance of endometrial pathologies, especially for endometrial cancer, of breast cancer patients under tamoxifen treatment European Journal of Gynaecological Oncology 30(4): 357-360
Tavani, A.; La Vecchia, C.; Brinton, L.A.; McTiernan, A. 2001: Hormone replacement therapy and risk of endometrial cancer Tumori 87(5): S20-S21
Cook, L.S.; Dong, Y.; Round, P.; Huang, X.; Magliocco, A.M.; Friedenreich, C.M. 2014: Hormone contraception before the first birth and endometrial cancer risk Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 23(2): 356-361
Schapira, D.V.; Kumar, N.B.; Lyman, G.H.; Cavanagh, D.; Roberts, W.S.; LaPolla, J. 1991: Upper-body fat distribution and endometrial cancer risk JAMA 266(13): 1808-1811
1987: Combination oral contraceptive use and the risk of endometrial cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development JAMA 257(6): 796-800
Tomica, D.; Ramić, S.; Danolić, D.; Knezević, F.; Kolak, T.; Balja, M.P.ć; Alvir, I.; Mamić, I.; Puljiz, M. 2014: A correlation between the expression of estrogen receptors and progesterone receptors in cancer cells and in the myometrium and prognostic factors in endometrial cancer Collegium Antropologicum 38(1): 129-134
Sawicki, W.; Spiewankiewicz, B.; Stelmachów, J.; Cendrowski, K. 2003: The value of ultrasonography in preoperative assessment of selected prognostic factors in endometrial cancer European Journal of Gynaecological Oncology 24(3-4): 293-298
Brooks, S.E. 1997: A review of screening and early detection of endometrial cancer and use of risk assessment Journal of the Association for Academic Minority Physicians: the Official Publication of the Association for Academic Minority Physicians 8(2): 34-37